Efficacy and tolerability of rupatadine at four times the recommended dose against histamine- and platelet-activating factor-induced flare responses and ex vivo platelet aggregation in healthy malesCHURCH, M. K.British journal of dermatology (1951). 2010, Vol 163, Num 6, pp 1330-1332, issn 0007-0963, 3 p.Article

Antihistaminic effects of rupatadine and PKPD modellingPENA, Juana; CARBO, Marcel-Li; SOLANS, Anna et al.European journal of drug metabolism and pharmacokinetics. 2008, Vol 33, Num 2, pp 107-116, issn 0378-7966, 10 p.Article

Rupatadine for the treatment of urticariaNETTIS, Eustachio; DONNE, Pantalea Delle; DI LEO, Elisabetta et al.Expert opinion on pharmacotherapy. 2013, Vol 14, Num 13, pp 1807-1813, issn 1465-6566, 7 p.Article

Rupatadine Inhibits Proinflammatory Mediator Secretion from Human Mast Cells Triggered by Different StimuliVASIADI, Magdalini; KALOGEROMITROS, Dimitris; KEMPURAJ, Duraisamy et al.International archives of allergy and immunology. 2010, Vol 151, Num 1, pp 38-45, issn 1018-2438, 8 p.Article

Once-daily rupatadine improves the symptoms of chronic idiopathic urticaria : a randomised, double-blind, placebo-controlled studyDUBERTRET, Louis; ZALUPCA, Lavinia; CRISTODOULO, Tania et al.EJD. European journal of dermatology. 2007, Vol 17, Num 3, pp 223-228, issn 1167-1122, 6 p.Article

High performance liquid chromatography-tandem mass spectrometric determination of rupatadine in human plasma and its pharmacokineticsYUAN TIAN; JINGJING ZHANG; HUI LIN et al.Journal of pharmaceutical and biomedical analysis. 2008, Vol 47, Num 4-5, pp 899-906, issn 0731-7085, 8 p.Article

Randomized, Single-Blind, Crossover Comparison of Two Rupatadine Tablet Formulations on Histamine-Induced Cutaneous Response in Healthy Adult VolunteersUSHARANI, Pingali; NAIDU, Maddireddi U. R; PARTHASARATHY REDDY, B. S et al.Current therapeutic research. 2007, Vol 68, Num 6, pp 400-408, issn 0011-393X, 9 p.Article

Rupatadine 10 mg and ebastine 10 mg in seasonal allergic rhinitis: a comparison studyGUADANO, E. M; SERRA-BATLLES, J; MESEGUER, J et al.Allergy (Copenhagen). 2004, Vol 59, Num 7, pp 766-771, issn 0105-4538, 6 p.Article

Rupatadine, a new nonsedating antihistamine and PAF antagonistMERLOS, M.Methods and findings in experimental and clinical pharmacology. 2002, Vol 24, issn 0379-0355, p. 37, SUPAConference Paper

Heart Rhythm Disturbances Associated With Rupatadine : A Case Series From the Spanish and Portuguese Pharmacovigilance SystemsCARVAJAL, A; MACIAS, D; POMBAL, R et al.Clinical pharmacology and therapeutics. 2009, Vol 85, Num 5, pp 481-484, issn 0009-9236, 4 p.Article

Influence of food on the oral bioavailability of rupatadine tablets in healthy volunteers : A single-dose, randomized, open-label, two-way crossover studySOLANS, Anna; CARBO, Marcel-Li; PENA, Juana et al.Clinical therapeutics. 2007, Vol 29, Num 5, pp 900-908, issn 0149-2918, 9 p.Article

Rupatadine and its effects on symptom control, stimulation time, and temperature thresholds in patients with acquired cold urticariaMETZ, Martin; SCHOLZ, Elisabeth; FERRAN, Marta et al.Annals of allergy, asthma, & immunology. 2010, Vol 104, Num 1, pp 86-92, issn 1081-1206, 7 p.Article

Rupatadine in allergic rhinitis and chronic urticariaMULLOL, J; BOUSQUET, J; VAN CAUWENBERGE, P et al.Allergy. Supplement. 2008, Vol 63, Num 87, pp 5-28, issn 0108-1675, 24 p.Article

Effects of rupatadine vs placebo on allergen- induced symptoms in patients exposed to aeroallergens in the vienna challenge chamberSTUEBNER, Petra; HORAK, Friedrich; ZIEGLMAYER, René et al.Annals of allergy, asthma, & immunology. 2006, Vol 96, Num 1, pp 37-44, issn 1081-1206, 8 p.Article

Rupatadine in the treatment of chronic idiopathic urticaria : a double-blind, randomized, placebo-controlled multicentre studyGIMENEZ-ARNAU, A; PUJOL, R. M; IANOSI, S et al.Allergy (Copenhagen). 2007, Vol 62, Num 5, pp 539-546, issn 0105-4538, 8 p.Article

Simultaneous determination of rupatadine and its metabolite desloratadine in human plasma by a sensitive LC-MS/MS method : Application to the pharmacokinetic study in healthy Chinese volunteersJUN WEN; ZHANYING HONG; YIWEN WU et al.Journal of pharmaceutical and biomedical analysis. 2009, Vol 49, Num 2, pp 347-353, issn 0731-7085, 7 p.Article

Rupatadine does not potentiate the CNS depressant effects of Iorazepam: randomized, double-blind, crossover, repeated dose, placebo-controlled studyGARCIA-GEA, Consuelo; ROSA BALLESTER, Maria; MARTINEZ, Juan et al.British journal of clinical pharmacology. 2010, Vol 69, Num 6, pp 663-674, issn 0306-5251, 12 p.Article

A 12-week placebo-controlled study of rupatadine 10 mg once daily compared with cetirizine 10 mg once daily, in the treatment of persistent allergic rhinitisFANTIN, S; MASPERO, J; BISBAL, C et al.Allergy (Copenhagen). 2008, Vol 63, Num 7, pp 924-931, issn 0105-4538, 8 p.Article

No cardiac effects of therapeutic and supratherapeutic doses of rupatadine: results from a 'thorough QT/QTc study' performed according to ICH guidelinesDONADO, Ester; IZQUIERDO, Iñaki; PEREZ, Iñaki et al.British journal of clinical pharmacology. 2010, Vol 69, Num 4, pp 401-410, issn 0306-5251, 10 p.Article

Pharmacokinetic and Safety Profile of Rupatadine When Coadministered with Azithromycin at Steady-State Levels : A Randomized, Open-Label, Two-Way, Crossover, Phase I StudySOLANS, Anna; IZQUIERDO, Inaki; DONADO, Esther et al.Clinical therapeutics. 2008, Vol 30, Num 9, pp 1639-1650, issn 0149-2918, 12 p.Article

Central and peripheral evaluation of rupatadine, a new antihistamine/ platelet-activating factor antagonist, at different doses in healthy volunteersBARBANOJ, Manel J; GARCIA-GEA, Consuelo; MONE, Adelaida et al.Neuropsychobiology. 2004, Vol 50, Num 4, pp 311-321, issn 0302-282X, 11 p.Article

Rupatadine (WYSTAMM°) : Un autre antihistaminique H1 proche de la loratadine, sans plus = Rupatadine (WYSTAMM °): another H1-receptor antagonist close to the loratadine, no moreLa Revue Prescrire. 2009, Vol 29, Num 306, pp 247-247, issn 0247-7750, 1 p.Article

Effects of rupatadine, a new dual antagonist of histamine and platelet-activating factor receptors, on human cardiac Kv1.5 channelsCABALLERO, R; VALENZUELA, C; LONGOBARDO, M et al.British journal of pharmacology. 1999, Vol 128, Num 5, pp 1071-1081, issn 0007-1188Article

Determination of rupatadine in pharmaceutical formulations by a validated stability-indicating MEKC methodRUBERT NOGUEIRA, Daniele; DA SILVA SANGOI, Maximiliano; MAGALHAES DA SILVA, Lucélia et al.Journal of separation science. 2008, Vol 31, Num 16-17, pp 3098-3105, issn 1615-9306, 8 p.Article

Efficacy and safety of rupatadine for allergic rhino-conjunctivitis: a systematic review of randomized, double-blind, placebo-controlled studies with meta-analysisCOMPALATI, Enrico; CANONICA, Giorgio Walter.Current medical research and opinion. 2013, Vol 29, Num 11, pp 1539-1551, issn 0300-7995, 13 p.Article